KEYNOTE PRESENTERS:

Natalie Garcon, PharmD, Ph.D.
Vice President and Head of Research
GSK Biologicals

Norman Baylor, Ph.D.
Director, Office of Vaccines
FDA

Gregory Milman, Ph.D.
Director, Office of Innovations
NIAID / NIH

DISTINGUISHED PRESENTERS:

Erich Cerny
CSO
Chilka Ltd.

Wangxue Chen
Senior Research Officer
National Research Council Canada

Chris Colwell
Senior Advisor
McKenna Long & Aldridge LLP

Tarek Fahmy
Assistant Professor
Yale University

Charlotte Dabla
CEO
Epixis

Thomas Kleen
Director
Cellular Technology Limited

Clem Lewin, Ph.D.
Head, Strategic Immunization Planning
Novartis Vaccines & Diagnostics

Niranjan Kanesa-thasan, Ph.D.
Director, Clinical Early Development Cluster
Novartis Vaccines

Vince Pozsgay
Staff Scientist
NIH

Frank Rapoport
Partner
McKenna, Long, & Aldridge

Marjorie Robert-Guroff
Chief, Immune Biology of Retroviral Infection Section
NIH/NCI

Kenneth Rosenthal
Professor
NEOUCOM

Phillip Savage
Consultant in Medical Oncology
Charing Cross Hospital

Angela Shen
International Policy Analyst-Vaccine Specialist, National Vaccine Program Office
DHHS

Raymond Strikas
National Vaccine Program Office
DHHS

William Warren
President and CEO
VaxDesign

Julie Wilkinson
Custom BioPharma Solutions
Beckman Coulter, Inc.

Daniel Zimmerman
Senior Vice President Research and Development, Cellular Immunology
CEL-SCI Corporation


Please check back for updates!